Catalyst Wire Dossier Catalyst Wire Dossier

Silibinin

silibinin
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Silibinin, covering 2015-03-05 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients [NA]

See pricing